Form 4 for HCWB HCW Biologics Inc.
Accepted 2023-06-09 00:00:00 ET · period of report 2023-06-08 · accession 0001209191-23-036087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-09 | 2023-06-08 | HCWB | Flowers Lee | SVP of Business Development | P - Purchase | $2.16 | +10.0K | 111.3K | +10% | +$21.6K |
| D | 2023-06-09 | 2023-06-08 | HCWB | Flowers Lee | SVP of Business Development | M - OptEx | $0.14 | +5,356 | 101.3K | +6% | +$749.84 |
| D | 2023-06-09 | 2023-06-08 | HCWB | Flowers Lee | SVP of Business Development | M - OptEx | $0.00 | -5,356 | 7,501 | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-08 | P | A | 10,000 | $2.16 | 111,308 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-08 | M | A | 5,356 | $0.14 | 101,308 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-06-08 | M | D | 5,356 | $0.00 | 7,501 | D | $0.14 · — to 2029-09-18 | 5,356 Common Stock | (F1) 20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023. |